CSLLY
CSL LTD-SPON ADR
Health Care·Biotechnology·AUSTRALIA
$17.44
MCap $33.4B
as of 2026-06-09
Total
E1w
Fund
E1w
Quant
E1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.60
Sentiment 16.4%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$17.44
Adaptive Mean
$16.80
+0.64 vs mean
Adaptive σ
0.53
MIDOS BB
$15.74 – $17.87
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.48
ROE
7.5%
Z +0.37
Rev Gr
—
Z —
EPS Gr
—
Z —
OPM Gr
—
Z —
FCF Yld
8.9%
Z +0.59
EPS Surp
—
Z —
EPS 3mo Δ
—
Z —
Fwd P/E
11.09
Z —
PEGY
0.03
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-19.73
Q6M
-15.46
Q12M
-11.62
MA 30/100
0.781
Bearish (MA30 < MA100)
α (Jensen)
-1.6670
β (12M)
0.64
σ (12M)
0.391
Divergence — Fundamentals vs Momentum
Z Percentile
92%
Q Percentile
1%
Divergence
+90.8
Tier
RELOAD — WATCH
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
-49.8
RS Pctl
5%
RS Decile
D1
Persistence
1w
at grade E
Options / OI Analysis
No options or Williams data available for this ticker.